Rombo L, Bergqvist Y, Hellgren U
Bull World Health Organ. 1987;65(6):879-83.
The concentrations of chloroquine and desethylchloroquine in the blood of 10 healthy adult Swedish volunteers who had been taking 310 mg chloroquine base once a week for at least 8 months for malaria prophylaxis were measured. Samples of capillary whole blood from the volunteers were dried on filter-paper and the drug and its principal metabolite determined by a specific high-performance liquid chromatography (HPLC) method. The day after taking the drug, the mean concentration of chloroquine and desethylchloroquine in whole blood were 1305 nmol/l and 915 nmol/l, respectively, and immediately before the next weekly dose, 489 nmol/l and 384 nmol/l, respectively. These are considered to be greater than the minimum inhibitory concentrations for susceptible strains but less than the maximum tolerated concentrations. The dosage of chloroquine recommended roughly 40 years ago for regular long-term prophylaxis should therefore not be changed.
对10名健康的成年瑞典志愿者进行了检测,这些志愿者为预防疟疾,每周服用310毫克氯喹碱至少8个月,检测他们血液中氯喹和去乙基氯喹的浓度。志愿者的毛细血管全血样本在滤纸上干燥,然后通过特定的高效液相色谱(HPLC)法测定药物及其主要代谢物。服药后的第二天,全血中氯喹和去乙基氯喹的平均浓度分别为1305纳摩尔/升和915纳摩尔/升,在下一次每周剂量服药前,分别为489纳摩尔/升和384纳摩尔/升。这些浓度被认为高于敏感菌株的最低抑菌浓度,但低于最大耐受浓度。因此,大约40年前推荐的用于常规长期预防的氯喹剂量不应改变。